Siemens Healthineers AG (SEMHF) Gets a Hold Rating from Independent Research

Independent Research analyst Tobias Gottschalt maintained a Hold rating on Siemens Healthineers AG (SEMHF) today and set a price target of EUR51.00. The company’s shares closed last Tuesday at $57.95, close to its 52-week high of $60.50.

According to, Gottschalt is ranked #6642 out of 7491 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Siemens Healthineers AG with a $62.98 average price target, an 8.7% upside from current levels. In a report issued on April 29, Barclays also maintained a Hold rating on the stock with a EUR47.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $60.50 and a one-year low of $42.75. Currently, Siemens Healthineers AG has an average volume of 475.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts